Abstract 4716: Functional precision medicine: Uncovering high actionability in rare cancers beyond genomics
Rachele Rosati(Precision for Medicine (United States)), Carla Grandori(Precision for Medicine (United States)), Lauren Appleyard(Precision for Medicine (United States)), Kiran K. Turaga(Yale New Haven Hospital), Jill Alldredge(Advanced Emissions Solutions (United States)), Alex Rajewski(Precision for Medicine (United States)), Soledad Jorge(University of Washington), Heidi J. Gray(Seattle Cancer Care Alliance), Arun D. Singh(Cleveland Eye Clinic), Barbara A. Goff(University of Washington), Ryan Jones(Tempus Labs (United States)), Payel Chatterjee(Precision for Medicine (United States)), Pashtoon Murtaza Kasi(Cornell University), Brady Bernard(Providence Portland Medical Center), Elizabeth M. Swisher(University of Washington), Marwah Al-Aloosi(Precision for Medicine (United States)), Kathryn P. Pennington(University of Washington), Christopher J. Kemp(Fred Hutch Cancer Center), Robert L. Diaz, Shalini Pereira(Precision for Medicine (United States)), Michael Castro(Beverly Hills Cancer Center), Vaishnavi Pallem(Precision for Medicine (United States)), Tara Elisabeth Seery
Cited by 1
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Colorectal cancer
|The Lancet|2019|5k
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
|Cancer Discovery|2017|964